Impaired endothelial function and increased plasminogen activator inhibitor 1 (PAI-1) activity in patients with DM result in a greater risk of late in-stent thrombotic events after PCI, which is already more common with first-generation DES compared to BMS intervention [70]. The gene discussed is SERPINE1; the disease is diabetes mellitus.